JP2016540021A5 - - Google Patents

Download PDF

Info

Publication number
JP2016540021A5
JP2016540021A5 JP2016539161A JP2016539161A JP2016540021A5 JP 2016540021 A5 JP2016540021 A5 JP 2016540021A5 JP 2016539161 A JP2016539161 A JP 2016539161A JP 2016539161 A JP2016539161 A JP 2016539161A JP 2016540021 A5 JP2016540021 A5 JP 2016540021A5
Authority
JP
Japan
Prior art keywords
dosage form
unit dosage
solid unit
solid
form according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539161A
Other languages
English (en)
Japanese (ja)
Other versions
JP6447931B2 (ja
JP2016540021A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/077127 external-priority patent/WO2015086643A1/en
Publication of JP2016540021A publication Critical patent/JP2016540021A/ja
Publication of JP2016540021A5 publication Critical patent/JP2016540021A5/ja
Application granted granted Critical
Publication of JP6447931B2 publication Critical patent/JP6447931B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539161A 2013-12-12 2014-12-10 エステトロール成分を含有する口腔内崩壊固体単位剤形 Expired - Fee Related JP6447931B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13196904 2013-12-12
EP13196904.0 2013-12-12
PCT/EP2014/077127 WO2015086643A1 (en) 2013-12-12 2014-12-10 Orally disintegrating solid dosage unit containing an estetrol component

Publications (3)

Publication Number Publication Date
JP2016540021A JP2016540021A (ja) 2016-12-22
JP2016540021A5 true JP2016540021A5 (enExample) 2018-01-25
JP6447931B2 JP6447931B2 (ja) 2019-01-09

Family

ID=49759137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016539161A Expired - Fee Related JP6447931B2 (ja) 2013-12-12 2014-12-10 エステトロール成分を含有する口腔内崩壊固体単位剤形

Country Status (30)

Country Link
US (2) US9884064B2 (enExample)
EP (1) EP3079671B1 (enExample)
JP (1) JP6447931B2 (enExample)
KR (1) KR102265150B1 (enExample)
CN (1) CN105979935B (enExample)
AU (1) AU2014363599B2 (enExample)
BR (1) BR112016013502B1 (enExample)
CA (1) CA2932855C (enExample)
CL (1) CL2016001411A1 (enExample)
CY (1) CY1119817T1 (enExample)
DK (1) DK3079671T3 (enExample)
EA (1) EA032306B1 (enExample)
ES (1) ES2655076T3 (enExample)
HR (1) HRP20180129T1 (enExample)
HU (1) HUE035848T2 (enExample)
IL (1) IL246082B (enExample)
LT (1) LT3079671T (enExample)
MA (1) MA39105B1 (enExample)
MX (1) MX369035B (enExample)
NO (1) NO3079671T3 (enExample)
NZ (1) NZ720906A (enExample)
PL (1) PL3079671T3 (enExample)
PT (1) PT3079671T (enExample)
RS (1) RS56738B1 (enExample)
SG (1) SG11201604741UA (enExample)
SI (1) SI3079671T1 (enExample)
SM (1) SMT201700582T1 (enExample)
TN (1) TN2016000230A1 (enExample)
WO (1) WO2015086643A1 (enExample)
ZA (1) ZA201603903B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012264602B2 (en) 2011-06-01 2017-03-09 Estetra Srl Process for the production of estetrol intermediates
WO2012164095A1 (en) 2011-06-01 2012-12-06 Estetra S.A. Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
EP2741824B1 (en) * 2011-08-11 2017-05-03 Estetra S.P.R.L. Use of estetrol as emergency contraceptive
HRP20210668T1 (hr) * 2015-06-18 2021-05-28 Estetra Sprl Orodisperzibilna tableta koja sadrži estetrol
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
UA123099C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована в порожнині рота одиниця дозування, яка містить естетрольний компонент
US20160367567A1 (en) * 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
US20200046729A1 (en) * 2016-08-05 2020-02-13 Estetra Sprl Methods using combined oral contraceptive compositions with reduced cardiovascular effects
CA3178181A1 (en) * 2018-02-07 2019-08-15 Estetra Srl Contraceptive composition with reduced cardiovascular effects
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) * 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
JP7588140B2 (ja) * 2019-09-27 2024-11-21 インダストリアレ チミカ ソシエタ ア レスポンサビリタ リミタータ （１５α，１６α，１７β）－エストラ－１，３，５（１０）－トリエン－３，１５，１６，１７－テトロール（エステトロール）および当該製法の中間体を調製するためのプロセス
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN113552768B (zh) 2020-04-24 2025-06-17 爱天思株式会社 感光性着色组合物、彩色滤光片及图像显示装置
WO2022069956A1 (en) 2020-09-29 2022-04-07 Millicent Pharma Limited Orodispersible formulations
AU2023428138A1 (en) 2023-02-02 2025-09-04 Industriale Chimica S.R.L. PROCESS FOR PREPARING (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROL (ESTETROL) MONOHYDRATE
TW202533830A (zh) 2024-02-28 2025-09-01 比利時商埃斯特拉有限公司 雌四醇多晶型及其生產
HUP2400151A1 (hu) 2024-02-28 2025-09-28 Richter Gedeon Nyrt Ösztetrol-monohidrát kristályosítási eljárás

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6117446A (en) 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
ES2278924T3 (es) * 2001-05-18 2007-08-16 Pantarhei Bioscience B.V. Composicion farmaceutica para el uso en terapia de sustitucion hormonal.
EP1260225A1 (en) 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
EP1390041B1 (en) * 2001-05-23 2009-11-25 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
PT1390042E (pt) 2001-05-23 2008-03-10 Pantarhei Bioscience Bv Sistema de administração de um medicamento que compreende estrogénio tetrahidroxilado destinado à contracepção hormonal
WO2003018026A1 (en) 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
US8026228B2 (en) 2001-11-15 2011-09-27 Pantarhei Bioscience B.V. Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
AU2002343249B2 (en) * 2002-02-21 2009-02-05 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin B12
GB0410616D0 (en) 2004-05-13 2004-06-16 Unilever Plc Antiperspirant or deodorant compositions
US20070048369A1 (en) 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
US20090221540A1 (en) 2006-01-09 2009-09-03 Pantarhei Bioscience B.V. Method of Treating An Acute Vascular Disorder
US20070286819A1 (en) * 2006-06-08 2007-12-13 Warner Chilcott Company, Inc. Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
MX2008014941A (es) * 2006-06-08 2008-12-10 Warner Chilcott Co Inc Metodos para administrar formas de dosificacion solida de etinil estradiol y profarmacos del mismo con biodisponibilidad mejorada.
WO2008067387A2 (en) * 2006-11-29 2008-06-05 Wyeth Estrogen/ serm and estrogen/ progestin bi-layer tablets
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0806543A2 (pt) * 2007-01-12 2014-04-22 Wyeth Corp Composições de comprimido em comprimido
ATE537833T1 (de) 2007-06-21 2012-01-15 Pantarhei Bioscience Bv Behandlung des mekoniumaspirationssyndroms mit östrogenen
WO2010033832A2 (en) 2008-09-19 2010-03-25 Evestra, Inc. Estriol formulations
DE102009007771B4 (de) * 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
CN102058604A (zh) * 2009-11-17 2011-05-18 北京万全阳光医学技术有限公司 一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
WO2014159377A1 (en) 2013-03-14 2014-10-02 Teva Women's Health, Inc. Compositions containing tanaproget and natural estrogens

Similar Documents

Publication Publication Date Title
JP2016540021A5 (enExample)
AU2014363599B2 (en) Orally disintegrating solid dosage unit containing an estetrol component
HRP20210555T1 (hr) Orodisperzibilna tableta koja sadrži estetrol
JP6446552B2 (ja) 体重と体脂肪減少に用いられる組成物およびその医薬品と使用
HRP20220332T1 (hr) Farmaceutski pripravak koji sadrži drospirenon za uporabu kao kontraceptiv
JP2015166379A5 (enExample)
TW200803857A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
JP2015038135A5 (enExample)
JP2008520736A5 (enExample)
JP2018517718A5 (enExample)
JP2010522137A5 (enExample)
JP2013529665A5 (enExample)
JP2008543758A5 (enExample)
FI3710000T3 (fi) Tradipitantti käytettäväksi gastropareesin hoidossa
HRP20131088T1 (hr) Äśvrsti farmaceutski pripravci s fiksnom dozom koji sadrže irbesartan i amlodipin, njihova priprava i terapijska primjena
JP2014221827A5 (enExample)
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
CN104606232A (zh) 一种氨咖黄敏胶囊及其制备方法
WO2021129735A1 (zh) 一种固体制剂及其制备方法和用途
RU2015132902A (ru) Новый быстрорастворимый состав гранул с улучшенной растворимостью
JP2018039810A5 (enExample)
CN104706604A (zh) 一种吡仑帕奈冻干口崩片及其制备方法
JP2016505050A5 (enExample)
JP2015120758A5 (enExample)
CN101015519B (zh) 一种氯雷他定口服复方药物组合物